A retrospective study of histologically proven cases of plasma cell myeloma during a 13-year period showed that bone scintigraphy was performed in 15 patients. With respect to radiologically shown areas of bone destruction, scanning revealed an increased (44%), normal (48%), or decreased (8%) radionuclide uptake. Abnormal scintigraphic findings were predominantly found in the axial parts of the skeleton. Abnormal isotope accumulations in the ossei occurred more often than normal uptake in symptomatic patients.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bataille R, Chevalier J, Rossi M, Sany J (1982) Bone scintigraphy in plasma-cell myeloma, a prospective study of 70 patients. Radiology 145: 801–804
Frank JW, Lebesque S, Buchanan RB (1982) The value of bone imaging in multiple myeloma. Eur J Nucl Med 7: 502–505
Koizumi K, Tonami N, Hisada K (1978) 99mTc-Diphosphonate bone scanning in 10 patients with multiple myeloma. Jpn J Nucl Med 15: 554–559
Wahner HW, Kyle RA, Beabout JW (1980) Scintigraphic evaluation of the skeleton in multiple myeloma. Mayo Cl Proc 55: 739–746
Waxman AD, Siemsen JK, Levine AM, Holdorf D, Suzuki R, Singer FR, Bateman J (1981) Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication. J Nucl Med 22: 232–236
About this article
Cite this article
Ampil, F.L., Mills, G.M. Bone scintigraphy in plasma cell myeloma. Eur J Orthop Surg Traumatol 9, 59–60 (1999). https://doi.org/10.1007/BF01695724
- Bone scan